KARACA, Ş. B. Et Al. 2014. Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects. 2014 ASCO Annual Meeting .

KARACA, Ş. B., ATMACA, H., bozkurt, e., sezgin, c., KARABULUT, B., & USLU, F. R., (2014). Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects . 2014 ASCO Annual Meeting

KARACA, ŞAZİYE Et Al. "Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects," 2014 ASCO Annual Meeting, 2014

KARACA, ŞAZİYE B. Et Al. "Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects." 2014 ASCO Annual Meeting , 2014

KARACA, Ş. B. Et Al. (2014) . "Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects." 2014 ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={ŞAZİYE BURÇAK KARACA Et Al. }, title={Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects}, congress name={2014 ASCO Annual Meeting}, city={}, country={}, year={2014}}